Yunlong Lu

1.3k total citations · 1 hit paper
29 papers, 954 citations indexed

About

Yunlong Lu is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Yunlong Lu has authored 29 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Organic Chemistry and 7 papers in Molecular Biology. Recurrent topics in Yunlong Lu's work include Metal complexes synthesis and properties (8 papers), Click Chemistry and Applications (6 papers) and Ferrocene Chemistry and Applications (5 papers). Yunlong Lu is often cited by papers focused on Metal complexes synthesis and properties (8 papers), Click Chemistry and Applications (6 papers) and Ferrocene Chemistry and Applications (5 papers). Yunlong Lu collaborates with scholars based in China, United States and Italy. Yunlong Lu's co-authors include Wukun Liu, Zhibin Yang, Mianli Bian, Xiaoyan Ma, Zhongren Xu, Zhenfan Wen, Qiuyue Lu, Min Shan, Ronald Gust and Lin Lv and has published in prestigious journals such as Chemical Society Reviews, Coordination Chemistry Reviews and Journal of Medicinal Chemistry.

In The Last Decade

Yunlong Lu

26 papers receiving 944 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent development of gold(i) and gold(iii) complexes as therapeutic agents for cancer diseases

2022 179 citations Yunlong Lu, Xiaoyan Ma et al. Chemical Society Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yunlong Lu China	17	426	377	263	106	102	29	954
Anastasia De Luca Italy	20	492 1.2×	388 1.0×	667 2.5×	103 1.0×	74 0.7×	43	1.3k
Kushtrim Kryeziu Austria	15	412 1.0×	185 0.5×	344 1.3×	85 0.8×	52 0.5×	25	846
Céline Loncle France	18	426 1.0×	302 0.8×	613 2.3×	62 0.6×	199 2.0×	25	1.3k
Peter M. Bruno United States	19	816 1.9×	453 1.2×	847 3.2×	74 0.7×	107 1.0×	25	1.7k
Ye Wu China	17	268 0.6×	167 0.4×	692 2.6×	45 0.4×	91 0.9×	54	1.2k
Darren McKerrecher United Kingdom	16	168 0.4×	466 1.2×	508 1.9×	129 1.2×	29 0.3×	28	1.2k
Zhong‐Zhu Chen China	20	159 0.4×	820 2.2×	499 1.9×	63 0.6×	75 0.7×	131	1.5k
Utpal Ghosh India	20	323 0.8×	174 0.5×	483 1.8×	68 0.6×	35 0.3×	46	950
Soumitra Kumar Choudhuri India	20	381 0.9×	280 0.7×	233 0.9×	34 0.3×	127 1.2×	34	1.0k
Boris Cvek Czechia	12	311 0.7×	220 0.6×	352 1.3×	33 0.3×	66 0.6×	22	842

Countries citing papers authored by Yunlong Lu

Since Specialization

Citations

This map shows the geographic impact of Yunlong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunlong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunlong Lu more than expected).

Fields of papers citing papers by Yunlong Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunlong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunlong Lu. The network helps show where Yunlong Lu may publish in the future.

Co-authorship network of co-authors of Yunlong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yunlong Lu. A scholar is included among the top collaborators of Yunlong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunlong Lu. Yunlong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Tianpeng, et al.. (2025). Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy. Journal of Medicinal Chemistry. 68(2). 1002–1020. 4 indexed citations

Liu, Lijuan, et al.. (2025). Advances in combination therapy for the treatment of estrogen receptor positive breast cancer. Chinese Chemical Letters. 36(10). 111451–111451. 1 indexed citations

Wang, Lingling, Xiaoyan Ma, Ling Zhou, et al.. (2025). Dual-Targeting TrxR-EGFR Alkynyl-Au(I) Gefitinib Complex Induces Ferroptosis in Gefitinib-Resistant Lung Cancer via Degradation of GPX4. Journal of Medicinal Chemistry. 68(5). 5275–5291. 5 indexed citations

Zhou, Ling, Yunlong Lu, Wei Liu, et al.. (2024). Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice. Experimental Hematology and Oncology. 13(1). 26–26. 16 indexed citations

Wen, Zhenfan, Zhibin Yang, Dahong Chen, et al.. (2024). Simultaneous Activation of Immunogenic Cell Death and cGAS-STING Pathway by Liver- and Mitochondria-Targeted Gold(I) Complexes for Chemoimmunotherapy of Hepatocellular Carcinoma. Journal of Medicinal Chemistry. 67(3). 1982–2003. 32 indexed citations

Lu, Yunlong, Lijuan Liu, Chao Liu, et al.. (2024). Discovery of novel quinoline scaffold selective estrogen receptor degraders (SERDs) for treatment of ER positive breast cancer with enhanced antiproliferative bioactivity through immunogenic cell death (ICD) effects. European Journal of Medicinal Chemistry. 275. 116534–116534. 2 indexed citations

Wang, Meiyu, et al.. (2024). Synthesis, characterization and anti-ovarian cancer activities of novel biphenyl-NHC-gold(I) complexes. Journal of Organometallic Chemistry. 1013. 123167–123167. 2 indexed citations

Lu, Yunlong, Yuan‐Hao Liu, Xiaoyan Ma, et al.. (2023). NHC-gold(I)-alkyne complexes induced hepatocellular carcinoma cell death through bioorthogonal activation by palladium complex in living system. Chinese Chemical Letters. 34(9). 108413–108413. 17 indexed citations

Liu, Lijuan, et al.. (2023). Research Progress on Bioactive Metal Complexes against ER-Positive Advanced Breast Cancer. Journal of Medicinal Chemistry. 66(4). 2235–2256. 14 indexed citations

10.

Xu, Zhongren, Qiuyue Lu, Min Shan, et al.. (2023). NSAID–Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer. Journal of Medicinal Chemistry. 66(12). 7813–7833. 24 indexed citations

11.

Yang, Zhibin, Mianli Bian, Lin Lv, et al.. (2023). Tumor-Targeting NHC–Au(I) Complex Induces Immunogenic Cell Death in Hepatocellular Carcinoma. Journal of Medicinal Chemistry. 66(6). 3934–3952. 45 indexed citations

12.

Lu, Yunlong, Haiping Hao, Xin Wang, et al.. (2023). Design, synthesis and biological evaluation of fluorinated selective estrogen receptor degraders (FSERDs) --- A promising strategy for advanced ER positive breast cancer. European Journal of Medicinal Chemistry. 253. 115324–115324. 6 indexed citations

13.

Yang, Zhibin, Sheng Huang, Yu Liu, et al.. (2022). Biotin-Targeted Au(I) Radiosensitizer for Cancer Synergistic Therapy by Intervening with Redox Homeostasis and Inducing Ferroptosis. Journal of Medicinal Chemistry. 65(12). 8401–8415. 36 indexed citations

14.

Lu, Yunlong, Xiaoyan Ma, Lin Lv, et al.. (2022). Recent development of gold(i) and gold(iii) complexes as therapeutic agents for cancer diseases. Chemical Society Reviews. 51(13). 5518–5556. 179 indexed citations breakdown →

15.

Xu, Zhongren, Jianqiang Xu, Shibo Sun, et al.. (2022). Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma. Redox Biology. 54. 102351–102351. 91 indexed citations

16.

Bian, Mianli, Rong Fan, Zhibin Yang, et al.. (2022). Pt(II)-NHC Complex Induces ROS-ERS-Related DAMP Balance to Harness Immunogenic Cell Death in Hepatocellular Carcinoma. Journal of Medicinal Chemistry. 65(3). 1848–1866. 65 indexed citations

17.

Huang, Sheng, et al.. (2021). Synthesis andin vitroanticancer activities of seleniumN‐heterocyclic carbene compounds. Chemical Biology & Drug Design. 98(3). 435–444. 15 indexed citations

18.

Sun, Ying, Yunlong Lu, Mianli Bian, et al.. (2020). Pt(II) and Au(III) complexes containing Schiff-base ligands: A promising source for antitumor treatment. European Journal of Medicinal Chemistry. 211. 113098–113098. 85 indexed citations

19.

Lu, Yunlong & Wukun Liu. (2020). Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer. Journal of Medicinal Chemistry. 63(24). 15094–15114. 68 indexed citations

20.

Bian, Mianli, et al.. (2020). Halo and Pseudohalo Gold(I)–NHC Complexes Derived from 4,5-Diarylimidazoles with Excellent In Vitro and In Vivo Anticancer Activities Against HCC. Journal of Medicinal Chemistry. 63(17). 9197–9211. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact